Do not use these medicines together with other medicines that contain semaglutide, tirzepatide or any other GLP-1 or GLP-1/GIP receptor agonists, unless your doctor tells you to
In addition, the antioxidants in these capsules help fight free radicals that can cause skin damage, hyperpigmentation, and premature aging
One of the earliest pieces of evidence of the association between thiols and skin came from the effect of an extract of human skin that contained an active sulfhydryl-containing compound
The first GLP-RA, twice-daily exenatide, was approved in the USA in 2005 [3] and, most recently, semaglutide received approval for administration by injection in 2017 [4] and in an oral formulation in 2019 [5]
In clinical trials, people who received Semaglutide injections lost an average of 12-15% of their body weight over a 68-week period